On Wednesday, Opexa Therapeutics Inc (NASDAQ:OPXA)’s shares inclined 24.97% to $0.600.
Opexa Therapeutics Inc (OPXA) declared that Dr. Jason Kralic has joined the company in the new role of Vice President of Business Development. Dr. Kralic will be responsible for business development activities, counting partnering, licensing and managing external relationships, and he will report directly to Neil Warma, President and CEO of Opexa.
Opexa’s lead T-cell immunotherapy therapy, Tcelna® received Fast Track designation from the U.S. FDA and is presently in development in a Phase 2b clinical trial for secondary progressive multiple sclerosis (SPMS). The trial is fully enrolled with data predictable in the second half of 2016. Opexa entered an option and license agreement with Merck Serono for Tcelna for the multiple sclerosis indications worldwide, not taking into account Japan. Opexa retains all rights to all other disease indications developed off its proprietary T-cell platform, counting OPX-212 which is in early, pre-IND development for the treatment of neuromyelitis optica (NMO), a rare (orphan) disease for which there are no approved treatments.
Opexa Therapeutics, Inc., a biopharmaceutical company, develops personalized immunotherapy to treat multiple sclerosis (MS) and other autoimmune diseases, such as neuromyelitis optica (NMO) based on its proprietary T-cell technology. The company’s product candidate is Tcelna, a novel T-cell immunotherapy, which is in Phase IIb clinical development for the treatment of patients with secondary progressive MS.
PulteGroup, Inc. (NYSE:PHM)’s shares gained 1.33% to $19.10.
Single female Boomers are showing no signs of slowing down in their personal or professional lives. In fact, 50 percent of female Boomers are still working and 79 percent are satisfied in their current job position according to new data from Del Webb, a national brand of PulteGroup, Inc. (PHM), one of the nation’s largest homebuilders and the leading builder of communities for active adults.
The second in a series of newly released data from the 2015 Del Webb Baby Boomer Survey (conducted online for PulteGroup by Harris Poll among 1,020 single female U.S. adults ages 50-68) finds 51 percent of single, working Boomer women plan to stay at their current job for at least five more years, and 34 percent plan to retire between the ages of 65-69. These findings comprise with trends seen in Del Webb communities, which show the average age of a homebuyer to be 62 and that many residents continue to work after moving into the community.
PulteGroup, Inc., through its auxiliaries, engages in the homebuilding business; mortgage banking operations; and title operations in the United States. The company is involved in the acquisition and development of land primarily for residential purposes; and the construction of housing on land. It offers various home designs, counting single-family detached, townhouses, condominiums, and duplexes under the Pulte Homes, Del Webb, and Centex brand names.
At the end of Wednesday’s trade, Walgreens Boots Alliance Inc (NASDAQ:WBA)‘s shares surged 1.57% to $85.49.
Walgreens Boots Alliance Inc (WBA) in partnership with MDLIVE, the nation’s leading provider of telehealth services, recently declared an expansion of its telehealth platform to users in Colorado, Illinois and Washington. The company also declared that in addition to mobile, users can now access the platform via the Walgreens website on desktop and tablet devices, in states where the service is presently offered.
Walgreens and MDLIVE first launched the platform last December through the Walgreens mobile application in California and Michigan. The service provides 24/7 access to MDLIVE’s network of U.S. board-certified doctors, and is planned to be accessible to users in 25 states by the end of 2015.
The service is accessible in both iOS and Android versions of the Walgreens mobile app, and the platform enables users to consult virtually with MDLIVE board-certified physicians for a range of acute conditions. Importantly, these physicians can e-prescribe medications when appropriate. Visits with a participating MDLIVE physician are only $49.
Walgreens Boots Alliance, Inc., together with its auxiliaries, operates a network of drugstores in the United States. It provides consumer goods and services, pharmacy, and health and wellness services through drugstores, in addition to through mail, and by telephone and online.
Centurylink Inc (NYSE:CTL), ended its Wednesday’s trading session with 0.59% gain, and closed at $32.26.
Centurylink Inc (CTL) declared the appointment of Richard Warley as managing director for its Europe, Middle East and Africa (EMEA) operations. Warley’s responsibilities in this role comprise developing sales strategy, driving revenue growth and owning client relationships, in addition to directing overall CenturyLink business in EMEA.
Warley joins CenturyLink from IPsoft, a provider of autonomic and cognitive solutions, where he held the position of chief executive officer. Warley also formerly served as CEO of KVH, a Tokyo-based company specialising in data centre, cloud, network and IT services. Prior to IPsoft and KVH, Warley held senior roles at Savvis between 2000 and 2008, counting the position of international managing director.
CenturyLink, Inc. provides various communications services to residential, business, governmental, and wholesale customers in the United States. It operates through two segments, Business and Consumer. The company offers broadband services, which allow customers to connect to the Internet through their existing telephone lines or fiber-optic cables; private line services for transmission of large amounts of data between sites; and multi-protocol label switching, a data networking technology to support real-time voice and video.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
